GSTP1 and plasma cell myeloma: In the specific case of multiple myeloma, no significant association was found between NAD(P)H:quinone oxidoreductase 1 Pro187Ser or GSTP1 Ile105Val polymorphisms and multiple myeloma risk and also GSTP1 allelic variation may not influence susceptibility to this malignancy.